TRAW · Traws Pharma, Inc.
$0.57
-0.03 (-4.83%)
At close · Aug 14
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These conditions raise substantial doubt about our ability to continue as a going concern through the one-year period after the date that the financial statements are issued.”View the 10-Q filed Aug 14, 2026
Market Cap
$8.78M
Shares
15.37M
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-07-14 | 520 | $0.68 | $354 |
| 2026-07-13 | 764 | $0.76 | $581 |
| 2026-07-10 | 2,290 | $0.68 | $1,557 |
| 2026-06-24 | 17,902 | $0.84 | $15,038 |
| 2026-06-23 | 1,339 | $0.89 | $1,192 |
| 2026-06-22 | 973,808 | $0.85 | $827,737 |
| 2026-06-18 | 1,381,354 | $0.80 | $1,105,083 |
| 2026-06-17 | 1,410,984 | $0.84 | $1,185,227 |
| 2026-06-16 | 1,410,869 | $0.76 | $1,072,260 |
| 2026-06-15 | 7,654 | $1.28 | $9,797 |
| 2026-06-08 | 13,685 | $1.37 | $18,748 |
| 2026-06-05 | 2,195 | $1.48 | $3,249 |
| 2026-06-03 | 15,725 | $1.42 | $22,330 |
| 2026-05-28 | 301 | $1.53 | $461 |
| 2026-05-27 | 4,037 | $1.58 | $6,378 |
| 2026-05-26 | 158,024 | $1.49 | $235,456 |
| 2026-05-22 | 193,231 | $1.49 | $287,914 |
| 2026-05-19 | 31,834 | $1.76 | $56,028 |
| 2026-05-18 | 43,996 | $1.88 | $82,712 |
Showing 1–19 of 19 settlements
Key facts
CIK
1130598
CUSIP
68232V884
13F (30d)
39 filings
38 filers
Visit website
Investor relations